Zepp Health Corporation reports developments in smart wearables and health technology through its NYSE-listed ADRs. The company’s updates center on Amazfit smartwatches and fitness devices, including performance running, rugged outdoor and active-lifestyle product lines, as well as Zepp Clarity and Zepp Aura consumer health brands.
Recurring news themes include Amazfit product introductions, connected training features, biometric and recovery tools, Zepp OS and related platform technology, brand partnerships in fitness communities, unaudited financial results, share repurchase and debt-management commentary, and annual Form 20-F reporting for the foreign private issuer.
Zepp Health (NYSE:ZEPP) unit Amazfit announced a new three-year global partnership with HYROX to expand a regional collaboration into a worldwide agreement. The deal grants Amazfit exclusive smart wearables presence across HYROX events and adds smart watches, rings, cameras, glasses, straps, app integrations, and HYROX-specific training modes.
The partnership also deepens collaboration across the HYROX 365 training network to support athlete training, racing, and recovery.
Zepp Health (NYSE: ZEPP) reported fourth-quarter 2025 revenue of US$85.2M (+43.0% YoY) and full-year revenue of US$258.9M (+41.8% YoY). Gross margin hit a company record of 40.4% in Q4, and cash (including restricted) was US$112.9M at year-end. GAAP net loss narrowed to US$11.0M in Q4 and US$40.1M for 2025; adjusted net loss was US$6.4M in Q4 and US$31.5M for 2025. Management guides Q1 2026 revenue of US$50.0M–US$55.0M (≈30%–43% YoY).
Zepp Health (NYSE: ZEPP) will report its unaudited fourth quarter and full year 2025 financial results on March 15, 2026. Management will host a conference call and live webcast at 9:30 p.m. ET the same day. A telephone replay will be available through March 22, 2026.
Dial‑in numbers and a webcast link are provided for US, international, China, and Hong Kong listeners; participants are asked to connect at least 10 minutes early.
Amazfit (ZEPP) launched the Active 3 Premium on February 26, 2026, a compact 4-button smartwatch aimed at entry-level runners and hybrid trainers. It features a 45mm stainless-steel frame, 1.32-inch AMOLED under Sapphire Glass, six-satellite GPS with offline maps, 4GB storage, and up to 12 days battery life. Priced at $169.99, it includes Zepp Coach plans, advanced running metrics, BioTracker health monitoring, Bluetooth calling, and integrations with TrainingPeaks, Strava, Runna, and Intervals.icu, targeting accessible structured training and phone-free runs.
Amazfit (ZEPP) unveiled the T-Rex Ultra 2 on February 19, 2026: a titanium, expedition-focused GPS watch with preloaded global maps, six-satellite positioning, and industry-grade durability.
Key specs include a 1.5-inch AMOLED, sapphire glass, Grade 5 titanium bezel, 10 ATM water resistance, 64 GB storage, up to 30 days battery, and a $549.99 price.
Amazfit (NYSE: ZEPP) returns to CES 2026 to showcase new sports‑tech concepts and products focused on a connected performance ecosystem. At Booth #52344 (Venetian Expo, Level 2) Amazfit previews two early‑stage concepts—V1TAL Food Camera for photo‑based nutrition analysis and Helio Glasses for a minimalist heads‑up display that shows pace, heart rate, and navigation when paired with an Amazfit smartwatch. Both concepts are prototypes; V1TAL and Helio features, pricing, and timing remain in development, with Helio targeting a potential release in H2 2026. Amazfit also launches the Active Max wearable (1.5" display, 24‑day battery, 170+ sport modes) priced at $169 and available now on amazfit.com and Amazon. Zepp Health will also exhibit Zepp Clarity OTC hearing aids at CES and Pepcom.
Zepp Health (NYSE: ZEPP) launches the Amazfit Active Max, a new smartwatch in the Active family available December 30, 2025 for $169. The device highlights a 1.5" ultra-bright AMOLED display with up to 3,000 nits, up to 25 days of battery life, and 4GB onboard storage supporting an estimated 100 hours of podcast playback.
Active Max adds BioCharge energy readiness, BioTracker PPG health monitoring, 170+ sport modes with AI Zepp Coach guidance, intelligent strength-training detection, Bluetooth calling, speech-to-text replies (Android), downloadable maps including 2,000+ ski resorts, and 5 ATM water resistance. The podcast feature will roll out via software update in February 2026.
Zepp Health (NYSE: ZEPP) reported third quarter 2025 unaudited results: revenue $75.8M (+78.5% YoY), GAAP operating loss narrowed to $0.9M while adjusted operating income reached breakeven. Gross margin was 38.2%, up 2.0 percentage points sequentially. Cash and restricted cash totaled $102.6M as of Sept 30, 2025, up from $95.3M June 30. Inventory was $87.7M as the company built stock for Q4 and new launches. Management guided Q4 2025 revenue to $82.0M–$86.0M (≈+38%–45% YoY) and said the share repurchase program will proceed in 2026.
Zepp Health (NYSE: ZEPP) will report its unaudited third quarter 2025 financial results after market close on Tuesday, November 4, 2025. Management will host a conference call at 8:30 p.m. Eastern Time the same day.
Investors may access the live webcast at http://ir.zepp.com or dial the listed toll-free and international numbers; participants should call at least 10 minutes early. A telephone replay will be available one hour after the call ends through November 11, 2025 using passcode 4560143.
Amazfit (NYSE: ZEPP), the Official Timing & Wearable Partner of HYROX, has expanded its athlete roster for the 2025/26 HYROX season. The team includes returning champion Hunter McIntyre and new additions Rich Ryan, Joanna Wietrzyk, Emilie Dahmen, and Linda Meier.
The expanded roster features both established champions and emerging talent, with Linda Meier being the reigning HYROX World Champion. The athletes will utilize various Amazfit products, including the T-Rex series, Balance 2, and Helio Strap, while contributing to product testing and development. The partnership aims to enhance athlete performance through data-driven insights and advanced wearable technology.